Please use this identifier to cite or link to this item:
Title: Post-transplantation diabetes - state of the art.
Epworth Authors: Cohney, Solomon (Shlomo)
Other Authors: Sharif, Adnan
Keywords: UroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australia
Department of Nephrology, Epworth HealthCare, Richmond, Victoria, Australia.
Department of Gastroenterology, Epworth HealthCare, Richmond, Victoria, Australia.
Diabetes Mellitus, Type 2
Type 2 Diabetes Mellitus
Insulin Resistance
Cardiovascular Diseases
Issue Date: Apr-2016
Publisher: Elsevier
Citation: Lancet Diabetes and Endocrinology. 2016 Apr;4(4):337-49.
Abstract: With increasing success in overcoming the immunological and infectious challenges accompanying solid organ transplantation, susceptibility to post-transplant diabetes and cardiovascular disease has assumed increasing importance. Although some guidance is available from diabetes-related literature pertaining to the general population, some aspects are unique to solid organ allograft recipients. Both insulin resistance and β-cell dysfunction are generally agreed to contribute to development and manifestation of post-transplant diabetes, but controversy continues about which is most important and to what extent post-transplant diabetes is a distinct entity or simply a variant of type 2 diabetes with transplant-specific components. The optimum method and timing for detection and diagnosis of post-transplant diabetes remains an area of uncertainty. However, the greatest needs are to: address the absence of contemporary data for incidence and clinical outcomes associated with post-transplant diabetes; establish the role of glycaemic control; and assess the role of new diabetic therapies in prevention and management of post-transplant diabetes. We place the present knowledge base in the context of other advances in transplantation, challenge some existing ideas, and examine the potential role of emerging diabetes therapies. In highlighting existing deficiencies, we hope to provide direction for future research that will ultimately reduce incidence and improve management of post-transplant diabetes.
DOI: 10.1016/S2213-8587(15)00387-3
PubMed URL:
ISSN: 2213-8587
Journal Title: Lancet Diabetes and Endocrinology.
Type: Journal Article
Affiliated Organisations: Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, UK.
Department of Nephrology, Western Hospital, Sunshine/Footscray, Victoria, Australia.
Department of Nephrology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Appears in Collections:Obstetrics & Gynaecology
UroRenal, Vascular
Cardiac Sciences

Files in This Item:
There are no files associated with this item.

Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.